Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

PDE10A inhibitors for the treatment of schizophrenia

Aug. 13, 2014

Preliminary results from validation study of Oncotype DX prostate cancer test

Aug. 12, 2014

Leica Biosystems and Bristol-Myers Squibb collaborate on companion diagnostics

Aug. 11, 2014

Oxford Immunotec acquires Boulder Diagnostics assets

Aug. 7, 2014

NanoString Technologies receives approval in Australia for breast cancer assay

Aug. 7, 2014

Amarantus reports data for LymPro Test and licenses property from University of Leipzig

Aug. 5, 2014

OncoCyte expands clinical development of bladder cancer diagnostic

Aug. 4, 2014

Glide Pharmaceutical licenses rights from FScan to prostate cancer diagnostic technology

July 31, 2014

New radiopharmaceutical metal complexes reported by Molecular InSight Pharmaceuticals

July 30, 2014

Akers signs feasibility deal with Konica Minolta to develop cardiac muscle tissue damage test

July 30, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...